Beyond #WorldDiabetesDay, Lilly’s focus on science and early action continues. This year’s #ActEarlyOnDiabetes theme is a shared mission that aligns with our work, moving forward, early action is still our goal. Follow us for more!
2
285
Every person living with #T2D has their own goals, needs and, life beyond diabetes. Early action starts with understanding the whole person, timely screening and, shared care decisions. This #WorldDiabetesDay, let’s put people at the centre and #ActEarlyOnDiabetes.
589M people are living with diabetes worldwide, with nearly half undiagnosed.¹,² Addressing cardiometabolic risk factors early may help reduce the global impact.³ Lilly is committed to raising awareness for early action on #WorldDiabetesDay. Follow us to learn more!
The first year after #T2D diagnosis matters. Achieving an HbA1c of <6.5% during this time may help reduce complication risks over time. This #WorldDiabetesDay, we’re highlighting the importance of early action. Follow us, learn more about why it matters to #ActEarlyOnDiabetes.
Lilly supports IDF Europe’s 2026 #WorldDiabetesDay campaign. Its Diabetes 360° exhibition shows how EU policy can shape prevention, early detection, and care. It also features dedicated health check stations as part of the #KnowYourNumbers campaign. #ActEarlyOnDiabetes
What changes when connected conditions are considered together? A #Cardiometabolic perspective on #T2D management may help improve long-term outcomes. From glucose levels to the wider cardiometabolic picture, our legacy is what we do next. Keep following us here!
2
365
Early action goes beyond awareness. It means recognizing the signs, understanding risk, and making screening and care accessible.¹⁻⁴ This #WorldDiabetesDay, Lilly is proud to partner with the International Diabetes Federation on its global campaign #ActEarlyOnDiabetes.⁴
This World Diabetes Day, how many adults are at risk of T2D due to impaired glucose tolerance? Find out in our next post. For HCPs only.
14%35 million
22%453 million
27%635 million
37%1 billion
6,222 votes • Final resultsBuilding on more than a century of diabetes care, we take #WorldDiabetesDay as an opportunity to acknowledge our patients, the science, and the innovations that continue to shape care. Follow us for more insights.
What if early action in T2D paid off for decades? The 24-year follow-up data from the UKPDS confirmed that intensive glycemic control soon after T2D diagnosis delivered a persistent legacy effect, helping to maintain lower HbA1c levels and reduce the lifetime risk of related complications.
What makes #T2D so complex? Currently, we know 11 mediating pathways of hyperglycemia, empowering personalized care for patients with T2D. Meet the Egregious Eleven.
When intensification of #T2D management is delayed by one year, people with HbA1c >7% face a higher risk of complications. Overcoming therapeutic inertia and acting earlier to reduce HbA1c is important for long-term outcomes.¹
2
1,083
Despite advances in #T2D care, more than 45% of people with T2D still do not reach their HbA1c goals. With personalized care and a holistic approach, we can change that—bringing us closer to the WHO's goal of 80% of patients achieving good glycemic control.
2
1,077
#T2D is a silent, progressive disease. But with early, proactive management, its associated complications may be prevented or delayed. Follow us for more insights!
1
1,567
The number of people living with diabetes continues to rise worldwide. Early and personalized care may help reduce the burden of #T2D — the most common form of the disease.
289
The week of #EASD2026 in Milan had one throughline – moving science into practice. Science is always evolving, and so should #Cardiometabolic care. Watch a Daily Takeaways recap of the congress with Dr. Hassanein.
3
2,698
Thank you to the scientific community, attendees, and partners at #EASD2026. We enjoyed the conversations that will help shape the future of #Cardiometabolic care. The next step is looking ahead. Follow us to stay informed.
1
529
What is next for #Cardiometabolic care? Science doesn't pause when #EASD2026 ends. From early intervention to long-term protection, what we have learned continues to advance cardiometabolic care. Stay with us, follow what's next!
485













